Patient and surgical characteristics
Number of patients | 153 |
Follow-up after PVR (years) | 9.6 (5.9, 13.3) |
Male gender | 95 (62%) |
Age at PVR (years) | 30.8±11 |
Initial correction | |
Myectomy/valvulotomy | 17 (11%) |
RV patch | 21 (14%) |
Transannular patch | 106 (69%) |
Other | 9 (6%) |
Age at initial correction (years) | 4.8 (2.4, 7.5) |
Previous shunt procedure | 73 (48%) |
Waterston | 31 (42%) |
Potts | 6 (8%) |
Blalock–Taussig | 32 (44%) |
Other | 4 (5%) |
Age at shunt procedure (years) | 1.5 (0.7,2.9) |
Down syndrome | 4 (3%) |
22q11 deletion | 5 (3%) |
Other cause of mental retardation | 8 (5%) |
History prior to PVR | |
Ventricular tachycardia | 15 (10%) |
Supraventricular tachycardia | 21 (14%) |
Heart failure | 6 (4%) |
QRS duration before PVR (ms) | 152±27 |
NYHA class ≥II before PVR | 67/119 (56%) |
Indication for PVR | |
Pulmonary regurgitation | 130 (85%) |
Other | 23 (15%) |
Surgical data | |
Type of RV outflow tract homograft | |
Pulmonary homograft | 147 (96%) |
Aortic homograft | 6 (4%) |
Previous PVR | 2 (1%) |
Concomitant procedures | |
Tricuspid valve plasty or ring | 29 (19%) |
RV aneurysm/patch resection | 52 (34%) |
Pulmonary artery angioplasty | 34 (22%) |
Ventricular septal defect closure | 9 (6%) |
Diameter homograft (mm) | 25.2±2.0 |
Data are described as number with frequency, mean with SD or median with IQR. Supraventricular and ventricular tachycardia were both defined as >30 s or requiring cardioversion.
NYHA, New York Heart Association; PVR, pulmonary valve replacement.